Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,483 | 148 | 73.8% |
| Consulting Fee | $835.93 | 2 | 24.9% |
| Education | $42.62 | 8 | 1.3% |
| Gift | $0.60 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $1,317 | 50 | $0 (2019) |
| AbbVie Inc. | $472.62 | 18 | $0 (2023) |
| Mission Pharmacal Company | $326.69 | 26 | $0 (2019) |
| Sumitomo Pharma America, Inc. | $120.28 | 5 | $0 (2024) |
| Lupin Inc. | $104.97 | 6 | $0 (2020) |
| Astellas Pharma US Inc | $102.32 | 5 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $96.54 | 4 | $0 (2019) |
| Allergan Inc. | $78.77 | 5 | $0 (2019) |
| SHIELD THERAPEUTICS INC | $76.75 | 1 | $0 (2024) |
| Sage Therapeutics, Inc. | $75.78 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $331.41 | 14 | Astellas Pharma US Inc ($79.00) |
| 2023 | $311.23 | 15 | AbbVie Inc. ($88.58) |
| 2022 | $22.90 | 1 | Boston Scientific Corporation ($22.90) |
| 2020 | $83.23 | 5 | AbbVie Inc. ($33.32) |
| 2019 | $529.26 | 31 | AbbVie, Inc. ($217.56) |
| 2018 | $1,334 | 39 | Vertical Pharmaceuticals, LLC ($913.22) |
| 2017 | $749.56 | 54 | Vertical Pharmaceuticals, LLC ($289.83) |
All Payment Transactions
159 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Biological | ||||||
| 10/29/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 10/01/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $76.75 | General |
| Category: Hematology | ||||||
| 09/09/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: HORMONE THERAPY | ||||||
| 09/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Biological | ||||||
| 07/16/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Biological | ||||||
| 05/15/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 05/07/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: HORMONE THERAPY | ||||||
| 04/17/2024 | Hologic Sales and Service, LLC | FLUENT FLUID MANAGEMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Surgical | ||||||
| 03/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Biological | ||||||
| 02/13/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 01/31/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: HORMONE THERAPY | ||||||
| 12/20/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $15.44 | General |
| 12/05/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: HORMONE THERAPY | ||||||
| 10/25/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: WOMENS HEALTH | ||||||
| 09/19/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $12.97 | General |
| 08/29/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: HORMONE THERAPY | ||||||
| 08/07/2023 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 08/01/2023 | Medtronic, Inc. | TRUCLEAR (Device) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: Hysteroscopy Systems | ||||||
| 07/25/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: WOMENS HEALTH | ||||||
| 07/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Biological | ||||||
| 06/13/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: ETONOGESTREL | ||||||
| 04/05/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 136 | 168 | $18,773 | $8,977 |
| 2022 | 3 | 101 | 119 | $13,446 | $6,373 |
| 2021 | 3 | 127 | 148 | $16,151 | $8,191 |
| 2020 | 3 | 95 | 104 | $11,561 | $5,181 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 73 | $9,813 | $4,885 | 49.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 50 | 50 | $5,900 | $2,055 | 34.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 45 | 45 | $3,060 | $2,038 | 66.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 55 | $7,394 | $3,539 | 47.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 34 | 34 | $4,012 | $1,441 | 35.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 30 | 30 | $2,040 | $1,393 | 68.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 57 | $7,663 | $4,070 | 53.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 45 | 45 | $3,060 | $2,145 | 70.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 46 | 46 | $5,428 | $1,977 | 36.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 45 | $6,049 | $2,488 | 41.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 29 | 29 | $1,972 | $1,367 | 69.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 30 | 30 | $3,540 | $1,326 | 37.5% |
About Dr. Lev Belder, DO
Dr. Lev Belder, DO is a Obstetrics & Gynecology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124139621.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lev Belder, DO has received a total of $3,362 in payments from pharmaceutical and medical device companies, with $331.41 received in 2024. These payments were reported across 159 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,483).
As a Medicare-enrolled provider, Belder has provided services to 459 Medicare beneficiaries, totaling 539 services with total Medicare billing of $28,722. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Philadelphia, PA
- Active Since 08/31/2006
- Last Updated 06/12/2008
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1124139621
Products in Payments
- CitraNatal (Drug) $324.93
- Orilissa (Drug) $231.82
- DIVIGEL (Drug) $204.05
- LO LOESTRIN FE (Drug) $167.35
- MYFEMBREE (Drug) $153.66
- CORVITE FE W QUATREFOLIC (Drug) $130.28
- SOLOSEC (Drug) $104.97
- Lupron (Drug) $103.72
- Veozah (Drug) $102.32
- Kyleena (Drug) $96.54
- ACCRUFER (Drug) $76.75
- ZURZUVAE (Drug) $75.78
- INJECTAFER (Drug) $71.29
- Prenate Mini (Drug) $58.27
- Endosee (Device) $35.46
- NUVARING (Drug) $35.13
- FLUENT FLUID MANAGEMENT SYSTEM (Device) $33.42
- ORILISSA (Drug) $33.32
- IMVEXXY (Drug) $29.84
- TRUCLEAR (Device) $27.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Philadelphia
Stephen Klasko, Md, MD
Obstetrics & Gynecology — Payments: $2.3M
Stephanie Sober, Md, MD
Obstetrics & Gynecology — Payments: $2.0M
Robert Burger, Md, MD
Obstetrics & Gynecology — Payments: $190,928
Jamille Nagtalon-Ramos, Crnp, CRNP
Obstetrics & Gynecology — Payments: $158,414
Dr. Anna Smith, Md, MD
Obstetrics & Gynecology — Payments: $77,240
Mathew Beshara, Md, MD
Obstetrics & Gynecology — Payments: $56,217